[1]
B. Setnik, PhD, K. Schoedel, PhD, C. Bartlett, MMath, C. Dick, MS, MBA, N. Hakim, MS, LLM, and P. Geoffroy, MDCM, MSc, FCFP, DABAM, “Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users”, J of Opioid Management, vol. 13, no. 6, pp. 449–464, Dec. 2017.